BRKR:NASDAQ
Bruker Corp
$56.54
arrow_upward
+1.69%(+0.94) 1D
$56.54
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 15, 4:00:01 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BRKR...
Open
$54.97
High
$57.01
Low
$54.44
Mkt. cap
8.61B
Avg. vol.
2.28M
Volume
2.11M
Dividend
0.35%
Quarterly dividend
$0.05
Ex-dividend date
Sep 21, 2026
52-wk high
$66.98
52-wk low
$32.36
EPS
-$0.70
Beta
1.22
Shares outstanding
152.36M
No. of employees
11K
Open
$54.97
High
$57.01
Low
$54.44
Mkt. cap
8.61B
Avg. vol.
2.28M
Volume
2.11M
Dividend
0.35%
Quarterly dividend
$0.05
Ex-dividend date
Sep 21, 2026
52-wk high
$66.98
52-wk low
$32.36
EPS
-$0.70
Beta
1.22
Shares outstanding
152.36M
No. of employees
11K
News stories
From web sources and news partners
ad-hoc-news.de
·
4 hours ago
J.P. Morgan downgrades Bruker stock and keeps USD 70.00 target
GuruFocus
·
1 day ago
J.P. Morgan Downgrades Bruker Corporation (BRKR) to Neutral Amid Revenue Growth Concerns
MarketBeat
·
1 day ago
Bruker (NASDAQ:BRKR) Stock Keeps Neutral Rating at JPMorgan Chase & Co.
Profile
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions.
In April 2010, Bruker created a Chemical Analysis Division under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography, and GC-triple quadrupole mass spectrometer.
In 2012, it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize. Wikipedia
About Bruker Corp
CEOFrank Laukien
Employees11.1K
Founded1960
HeadquartersBillerica, Massachusetts, United States
SectorHealth care
Websitebruker.com
Analyst ratings
Based on 10 analysts giving stock ratings to BRKR in the past 3 months
Buy
Buy
5
Hold
4
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BRKR in the last 3 months.
Highest
Current $56.54
$80.00 (+41.49%)
Average
$61.33 (+8.47%)
Lowest
$50.00 (-11.57%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Casey Woodring J.P. Morgan | Hold | Downgraded | $60.00 | +6.1% | 10/14/2026 |
Daniel Brennan TD Cowen | Hold | Maintained | $62.00 | +9.7% | 10/13/2026 |
Luke Sergott Barclays | Buy | Maintained | $70.00 | +23.8% | 10/07/2026 |
Unknown Analyst Goldman Sachs | Sell | Maintained | $50.00 | -11.6% | 10/05/2026 |
Evie Koslosky Goldman Sachs | Sell | Maintained | $50.00 | -11.6% | 10/05/2026 |
Subbu Nambi Guggenheim | Buy | Maintained | $72.00 | +27.3% | 10/01/2026 |
Puneet Souda Leerink Partners | Buy | Maintained | $80.00 | +41.5% | 09/29/2026 |
Michael Ryskin Bank of America Securities | Buy | Maintained | - | - | 08/05/2026 |
Evan Stampler Wells Fargo | Buy | Maintained | $55.00 | -2.7% | 08/05/2026 |
Unknown Analyst Wells Fargo | Buy | Maintained | $55.00 | -2.7% | 08/05/2026 |
Daniel Arias Stifel Nicolaus | Hold | Maintained | $50.00 | -11.6% | 08/05/2026 |
Patrick B Donnelly Citi | Hold | Maintained | $53.00 | -6.3% | 08/05/2026 |
Kyle Boucher TD Cowen | Hold | Maintained | $60.00 | +6.1% | 08/04/2026 |
Michael Polark Wolfe Research | Hold | Downgraded | - | - | 06/01/2026 |
Dan Leonard RBC Capital | Hold | Reiterated | $45.00 | -20.4% | 05/07/2026 |
Tycho Peterson Jefferies | Buy | Maintained | $50.00 | -11.6% | 02/12/2026 |
Last report
Aug 4, 2026
Fiscal period
Q2 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.49 / $0.38
+27.49%beat
arrow_upward
Revenue / Est. (USD)
838.50M / 853.57M
-1.77%miss
arrow_downward
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 860.50M | 977.20M | 823.40M | 838.50M |
Cost of goods sold | 446.30M | 510.40M | 428.20M | 421.40M |
Cost of revenue | 446.30M | 510.40M | 428.20M | 421.40M |
Research and development expenses | 98.30M | 99.60M | 101.30M | 94.30M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 242.50M | 244.20M | 242.10M | 238.90M |
Operating expense | 302.70M | 402.50M | 344.30M | 334.30M |
Total operating expenses | 749.00M | 912.90M | 772.50M | 755.70M |
Operating income | 111.50M | 64.30M | 50.90M | 82.80M |
Other non operating income | 9.30M | -5.70M | 3.00M | 4.00M |
EBT including unusual items | -72.60M | 67.00M | 18.20M | -36.70M |
EBT excluding unusual items | 106.60M | 54.20M | 47.30M | 87.90M |
Income tax expense | -14.10M | 37.80M | 2.50M | 14.20M |
Effective tax rate | 19.42% | 56.42% | 13.74% | -38.69% |
Other operating expenses | -38.10M | 58.70M | 800.00K | 1.10M |
Net income | -59.60M | 26.00M | 14.40M | -52.00M |
Net profit margin | -6.93% | 2.66% | 1.75% | -6.20% |
Earnings per share | 0.45 | 0.59 | 0.31 | 0.49 |
Interest and investment income | 4.40M | 4.60M | 4.90M | 11.30M |
Interest expense | -20.30M | -11.20M | -12.20M | -17.80M |
Net interest expenses | -15.90M | -6.60M | -7.30M | -6.50M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 167.20M | 122.40M | 109.20M | 140.80M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1